Piedmont Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-22,243
Closed -$3.94M 793
2020
Q1
$3.94M Buy
22,243
+16,056
+260% +$3.02M 0.16% 134
2019
Q4
$1.18M Buy
6,187
+1,072
+21% +$193K 0.04% 302
2019
Q3
$861K Buy
5,115
+546
+12% +$89K 0.03% 357
2019
Q2
$765K Sell
4,569
-488
-10% -$67.6K 0.03% 392
2019
Q1
$740K Sell
5,057
-19,901
-80% -$2.89M 0.03% 375
2018
Q4
$3.34M Buy
24,958
+1,656
+7% +$271K 0.16% 136
2018
Q3
$4.44M Buy
23,302
+8,575
+58% +$1.58M 0.19% 121
2018
Q2
$2.46M Sell
14,727
-35,798
-71% -$5.75M 0.12% 184
2018
Q1
$8.5M Sell
50,525
-21,701
-30% -$3.64M 0.23% 114
2017
Q4
$11.8M Sell
72,226
-243
-0.3% -$43.6K 0.24% 113
2017
Q3
$14.9M Buy
72,469
+662
+0.9% +$154K 0.32% 82
2017
Q2
$17.5M Buy
71,807
+763
+1% +$179K 0.39% 66
2017
Q1
$17M Buy
71,044
+504
+0.7% +$117K 0.35% 77
2016
Q4
$14.8M Sell
70,540
-10,929
-13% -$2.26M 0.3% 90
2016
Q3
$18.8M Sell
81,469
-8,420
-9% -$2.06M 0.41% 69
2016
Q2
$20.8M Buy
89,889
+1,881
+2% +$434K 0.43% 65
2016
Q1
$23.6M Buy
88,008
+1,352
+2% +$387K 0.5% 61
2015
Q4
$27.1M Buy
86,656
+767
+0.9% +$228K 0.57% 54
2015
Q3
$23.3M Buy
85,889
+688
+0.8% +$211K 0.53% 56
2015
Q2
$25.9M Buy
+85,201
New +$25.4M 0.55% 55

Other funds holding AGN

Piedmont Investment Advisors's AGN Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 22,243 shares — an estimated $3.94M sold.

Piedmont Investment Advisors first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $27.1M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 22,243 Allergan plc shares in Q2 2020, an estimated $3.94M.
  • Piedmont Investment Advisors first reported a position in Allergan plc in Q2 2015 and held it in 20 quarters.
  • Piedmont Investment Advisors's Allergan plc position peaked at $27.1M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.